tiprankstipranks
Trending News
More News >
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX

Eupraxia Pharmaceuticals (EPRX) Similar Stocks

Compare
21 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Eupraxia Pharmaceuticals
$6.29
C$318.36M
-7.24
82.96%
5 Buy
0 Hold
0 Sell
Strong Buy
Arch Biopartners
C$1.26
C$83.29M
-34.88
-24.71%
Medicenna Therapeutics Corp
C$1.08
C$74.23M
-6.37
-37.21%
2 Buy
0 Hold
0 Sell
Moderate Buy
Fennec Pharmaceuticals
C$11.25
C$357.45M
23.03%
2 Buy
0 Hold
0 Sell
Moderate Buy
NervGen Pharma
C$6.00
C$454.52M
-16.59
126.42%
1 Buy
0 Hold
0 Sell
Moderate Buy
Bright Minds Biosciences
C$122.40
C$1.03B
-92.57
117.75%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EPRX
Eupraxia Pharmaceuticals
6.29
3.29
109.67%
TSE:ARCH
Arch Biopartners
1.28
-0.44
-25.58%
TSE:MDNA
Medicenna Therapeutics Corp
1.08
-0.60
-35.71%
TSE:FRX
Fennec Pharmaceuticals
10.47
2.01
23.76%
TSE:NGEN
NervGen Pharma
6.00
2.87
91.69%
TSE:DRUG
Bright Minds Biosciences
122.40
68.00
125.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts